CHM

6.25%

1.7¢ chimeric therapeutics limited

I like to see CHM1101 licensed with a modest upfront fee and...

First 15 Last

Share
Profile

Follow
DrillDown2014

259 Posts.

62

08/06/24

20:49

Post #: 74232633
Share

Originally posted by mmcar2: ↑

My take from watching Rebecca's interview is that 1101 is ear marked to be sold. If you recall Hopper as chairman ,acquired it from City of Hope. I'm guessing that this was prior to Jen Chow's appointment . She said to me at a presentation that CDH17 was the program that excited her the most. Rebecca stated that CDH17 was the program that attracted her to CHM and it is CHM's main asset. The interviewer gave his view that he thought the NK platform was the 'company maker'.
The comment she made about 1101 was that it required a "very special procedure, that only a handful of neurosurgens are capable of doing this process ...to her knowledge there is only one surgeon in Australia capable of performing this task....it becomes a challenge".
The next generation NK platform cleverly incorporates 2301 and 1301 which are 'off the shelf' CAR NK therapies. We also have 0201 used in combination in other trials.
I get the impression CHM is moving from pure T cell therapies to NK therapies by developing CAR NK's . I my view 1101 doesn't fit into the new model.
Considering CHM's small market cap and hence the difficulty of raising cash, it make sense to offload 1101. I invite posters to put a reasonable value on 1101 were it to be sold prior to dose expansion.

Expand

I like to see CHM1101 licensed with a modest upfront fee and milestone payments. Below is what I would see as the value of the asset at this point.
Need some funds to progress the pipeline.

CHM could still run the trials for CHM1101 and while accessing funding for CHM2101 while CHM0201 is being progressed under investigator led and funded trials.

CHM Price at posting: 1.7¢ Sentiment: None Disclosure: Held
9 Upvote

1 Great analysis

Reply

Top Stories

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

HLX

Helix investor makes partial takeover bid, proposing board changes

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

There are more pages in this discussion • 8 more messages in this thread...

First 15 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.7¢		Change 0.001(6.25%)		Mkt cap ! $15.07M

Open	High	Low	Value	Volume
1.7¢	1.9¢	1.7¢	$45.06K	2.512M

Buyers (Bids)

No.	Vol.	Price($)
1	62187	1.7¢

Sellers (Offers)

Price($)	Vol.	No.
1.8¢	200000	1

View Market Depth

No.	Vol.	Price($)
1	62187	0.017
17	2833886	0.016
19	2586784	0.015
3	708475	0.014
2	222223	0.013

Price($)	Vol.	No.
0.019	1896071	5
0.020	1523093	7
0.021	290857	3
0.022	600000	2
0.023	150000	1

Last trade - 16.10pm 30/08/2024 (20 minute delay)

CHM (ASX) Chart

I like to see CHM1101 licensed with a modest upfront fee and...

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Helix investor makes partial takeover bid, proposing board changes

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Lendlease sells off US east coast construction operations in latest global divestment push

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I like to see CHM1101 licensed with a modest upfront fee and...

Top Stories

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Helix investor makes partial takeover bid, proposing board changes

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Lendlease sells off US east coast construction operations in latest global divestment push

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News